Hayamizu Kohsuke, Ishii Yuri, Kaneko Izuru, Shen Manzhen, Okuhara Yasuhide, Shigematsu Norihiro, Tomi Hironori, Furuse Mitsuhiro, Yoshino Gen, Shimasaki Hiroyuki
Central Research Laboratory, FANCL Corp., Kanagawa, Japan, ; Laboratory of Advanced Animal and Marine Bioresources, Faculty of Agriculture, Kyushu University, Fukuoka, Japan.
Central Research Laboratory, FANCL Corp., Kanagawa, Japan.
Curr Ther Res Clin Exp. 2003 Sep;64(8):551-67. doi: 10.1016/j.curtheres.2003.08.006.
(-)-Hydroxycitric acid (HCA) is an active ingredient extracted from the rind of the Indian fruit Garcinia cambogia. It inhibits adenosine triphosphate citrate lyase and has been used in the treatment of obesity.
The primary end point of this study was the effects of 12 weeks of G cambogia extract administration on visceral fat accumulation. The secondary end points were body indices (including height, body weight, body mass index [BMI], waist and hip circumference, and waist-hip ratio) and laboratory values (including total cholesterol, triacylglycerol, and free fatty acid).
This study was performed according to a double-blind, randomized, placebo-controlled, parallel-group design. Subjects aged 20 to 65 years with a visceral fat area >90 cm(2) were enrolled. Subjects were randomly assigned to receive treatment for 12 weeks with G cambogia (containing 1000 mg of HCA per day) or placebo. At the end of the treatment period, both groups were administered placebo for 4 weeks to assess any rebound effect. Each subject underwent a computed tomography scan at the umbilical level at -2, 0, 12, and 16 weeks.
Forty-four subjects were randomized at baseline, and 39 completed the study (G cambogia group, n = 18; placebo group, n = 21). At 16 weeks, the G cambogia group had significantly reduced visceral, subcutaneous, and total fat areas compared with the placebo group (all indices P<0.001). No severe adverse effect was observed at any time in the test period. There were no significant differences in BMI or body weight at week 12, but there were slight numeric decreases in body weight and BMI in men. There were no signs of a rebound effect from week 12 to week 16.
G cambogia reduced abdominal fat accumulation in subjects, regardless of sex, who had the visceral fat accumulation type of obesity. No rebound effect was observed. It is therefore expected that G cambogia may be useful for the prevention and reduction of accumulation of visceral fat.
(-)-羟基柠檬酸(HCA)是从印度藤黄果的果皮中提取的一种活性成分。它能抑制三磷酸腺苷柠檬酸裂解酶,已被用于治疗肥胖症。
本研究的主要终点是给予藤黄果提取物12周对内脏脂肪堆积的影响。次要终点是身体指标(包括身高、体重、体重指数[BMI]、腰围和臀围以及腰臀比)和实验室指标(包括总胆固醇、三酰甘油和游离脂肪酸)。
本研究按照双盲、随机、安慰剂对照、平行组设计进行。纳入年龄在20至65岁之间且内脏脂肪面积>90 cm²的受试者。受试者被随机分配接受藤黄果(每天含1000 mg HCA)或安慰剂治疗12周。在治疗期结束时,两组均给予安慰剂4周以评估任何反弹效应。每位受试者在第-2、0、12和16周时在脐水平进行计算机断层扫描。
44名受试者在基线时被随机分组,39名完成了研究(藤黄果组,n = 18;安慰剂组,n = 21)。在第16周时,与安慰剂组相比,藤黄果组的内脏、皮下和总脂肪面积显著减少(所有指标P<0.001)。在试验期间的任何时候均未观察到严重不良反应。在第12周时,BMI或体重无显著差异,但男性的体重和BMI有轻微的数值下降。从第12周到第16周没有反弹效应的迹象。
藤黄果可减少内脏脂肪堆积型肥胖受试者(无论性别)的腹部脂肪堆积。未观察到反弹效应。因此,预计藤黄果可能有助于预防和减少内脏脂肪堆积。